M. Costa-Garcia

Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors

R. Moreno, M. Costa-Garcia, JJ Rojas, 2024, Cancer immunology, immunotherapy : CII.

Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes

Z. Giricz, P. Ferdinandy, D. Matallanas, 2023, Open research Europe.

Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients

R. Sanz-Pamplona, Z. Trajanoski, M. Punta, 2022, bioRxiv.

High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer

F. Rojo, L. Comerma, J. Albanell, 2019, Cancer Immunology Research.

NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

A. Gonzalez-Perez, C. Rubio-Perez, D. Tamborero, 2018, Clinical Cancer Research.

Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes

A. Muntasell, M. López-Botet, C. Vilches, 2019, Front. Immunol..

Adaptive Features of Natural Killer Cells in Multiple Sclerosis

A. Zabalza, M. López-Botet, N. Villarrubia, 2019, Front. Immunol..

Antibody-Mediated Response of NKG2Cbright NK Cells against Human Cytomegalovirus

A. Muntasell, M. López-Botet, C. Vilches, 2015, The Journal of Immunology.

Priming of NK Cell Anti-Viral Effector Mechanisms by Direct Recognition of Human Cytomegalovirus

A. Muntasell, M. López-Botet, C. Kirschning, 2013, Front. Immun..

Cytomegalovirus Nk Cells against Human Bright Antibody-mediated Response of Nkg2c Antibody-mediated Response of Nkg2c Bright Nk Cells against Human Cytomegalovirus Materials and Methods Hcmv Stock Preparation and Mrc5 Infection

A. Muntasell, M. López-Botet, M. Moraru, 2022 .

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer

L. Comerma, S. Servitja, O. Arpí, 2024, Journal of experimental & clinical cancer research : CR.

Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients

J. Yélamos, J. Pascual, M. López-Botet, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System

Domènec Farré, A. Angulo, A. Muntasell, 2017, Front. Immunol..

Development of the adaptive NK cell response to human cytomegalovirus in the context of aging

A. Muntasell, M. López-Botet, J. Martínez-Rodríguez, 2016, Mechanisms of Ageing and Development.